. Show Affiliations »
Abstract
Entities: Gene
Mesh: See more » Cost ControlDiabetes Mellitus/drug therapyDiabetes Mellitus/economicsEnglandHIV Infections/economicsHIV Infections/prevention & controlHumansNeoplasms/drug therapyNeoplasms/economicsPre-Exposure Prophylaxis/economicsPublic Health/economicsState MedicineUnited Kingdom
Year: 2016 PMID: 27533425 DOI: 10.1016/S0140-6736(16)31343-5
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321